Krop Julie 4
4 · AMAG PHARMACEUTICALS INC. · Filed Jul 3, 2018
Insider Transaction Report
Form 4
Krop Julie
SVP Clinical & Regulatory, CMO
Transactions
- Tax Payment
Common Stock
2018-07-02$19.85/sh−2,161$42,896→ 49,475 total
Footnotes (1)
- [F1]Represents shares withheld to satisfy the reporting person's tax obligations in connection with the vesting of 7,335 restricted stock units ("RSUs") on June 1, 2018. Due to the black-out policies implemented by AMAG Pharmaceuticals, Inc. (the "Issuer"), the shares of the Issuer's Common Stock underlying such vested RSUs were not delivered to the reporting person until July 2, 2018, at which time 2,161 shares were withheld to satisfy the reporting person's applicable tax obligations.